Pfizer to Pay $103 Million for Drug Linked to Breast Cancer

by: cancercompass

Drug manufacturer Pfizer has been ordered to pay $103 million in punitive damages in two separate court cases involving Prempro, a hormone-replacement drug.

Both cases involve women who were diagnosed with breast cancer after using Prempro. According to The Philadelphia Inquirer, a jury awarded $28 million yesterday to a resident of Decatur, Illinois.  In the second case, a Philadelphia judge unsealed a verdict yesterday, which was reached earlier this year, awarding $75 million in punitive damages to another Illinois resident.

Pfizer recently acquired Prempro's manufacturer.  The New York Times reports that over 10,000 liability suits have been filed in the United States over the hormone drug.

Pfizer says the company will appeal yesterday's court rulings.